| Mortality due to cancer treatment delay: systematic review and meta-analysis TP Hanna, WD King, S Thibodeau, M Jalink, GA Paulin, E Harvey-Jones, ... bmj 371, 2020 | 1223 | 2020 |
| Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey A Fundytus, M Sengar, D Lombe, W Hopman, M Jalink, B Gyawali, ... Lancet Oncology, 2021 | 121 | 2021 |
| Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review … G Karam, A Agarwal, B Sadeghirad, M Jalink, CL Hitchcock, L Ge, ... Bmj 380, 2023 | 100 | 2023 |
| Oncology training and education initiatives in low and middle income countries: a scoping review S Karim, Z Sunderji, M Jalink, S Mohamed, I Mallick, ... Ecancermedicalscience 15, 1296, 2021 | 28 | 2021 |
| Changes in health care costs, survival, and time toxicity in the era of immunotherapy and targeted systemic therapy for melanoma SB Bateni, P Nguyen, A Eskander, SJ Seung, N Mittmann, M Jalink, ... JAMA dermatology 159 (11), 1195-1204, 2023 | 17 | 2023 |
| Severe respiratory syncytial virus infection in preterm infants and later onset of asthma MB Jalink, JM Langley, L Dodds, P Andreou The Pediatric Infectious Disease Journal 38 (11), 1121-1125, 2019 | 16 | 2019 |
| Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry DT Wijeratne, S Gunasekera, CM Booth, H Promod, M Jalink, U Jayarajah, ... BMC cancer 21, 1-8, 2021 | 14 | 2021 |
| A systematic review of eHealth technologies for breast cancer supportive care B Gyawali, M Bowman, I Sharpe, M Jalink, S Srivastava, DT Wijeratne Cancer Treatment Reviews 114, 102519, 2023 | 13 | 2023 |
| Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic D Lombe, R Sullivan, C Caduff, Z Ali, N Bhoo-Pathy, J Cleary, M Jalink, ... ecancermedicalscience 15, 1202, 2021 | 13 | 2021 |
| Strategies to prevent readmissions to hospital for COPD: a systematic review I Sharpe, M Bowman, A Kim, S Srivastava, M Jalink, DT Wijeratne COPD: Journal of Chronic Obstructive Pulmonary Disease 18 (4), 456-468, 2021 | 12 | 2021 |
| Cancer medicines: what is essential and affordable in India? M Sengar, A Fundytus, W Hopman, CS Pramesh, V Radhakrishnan, ... JCO global oncology 8, e2200060, 2022 | 11 | 2022 |
| Defining essential childhood cancer medicines to inform prioritization and access: results from an international, cross-sectional survey AE Denburg, A Fundytus, MS Khan, SC Howard, F Antillon-Klussmann, ... JCO global oncology 8, e2200034, 2022 | 10 | 2022 |
| Text messaging in cancer-supportive care: a systematic review DT Wijeratne, M Bowman, I Sharpe, S Srivastava, M Jalink, B Gyawali Cancers 13 (14), 3542, 2021 | 10 | 2021 |
| Oncology training programmes for general practitioners: a scoping review B Gyawali, M Jalink, SMA Effing, N Dalgarno, K Kolomitro, N Thapa, ... Ecancermedicalscience 15, 1241, 2021 | 10 | 2021 |
| Tracking the workforce 2020-2030: Making the case for a cancer workforce registry A Srivastava, M Jalink, FY de Moraes, CM Booth, SR Berry, F Rubagumya, ... JCO Global Oncology 7, 925-933, 2021 | 9 | 2021 |
| The palivizumab patchwork: variation in guidelines for respiratory syncytial virus prevention across Canadian provinces and territories M Jalink, JM Langley Paediatrics & Child Health 26 (2), e115-e120, 2021 | 9 | 2021 |
| Training general practitioners in oncology: a needs assessment survey from Nepal B Gyawali, N Thapa, C Savage, LM Carson, M Jalink, M Rawal, S Berry, ... JCO Global Oncology 8, e2200113, 2022 | 7 | 2022 |
| Clinical oncology workload in Sri Lanka: infrastructure, supports, and delivery of clinical care S Gunasekera, S Seneviratne, M Jalink, N Joseph, Y Ariyarathna, ... JCO Global Oncology 7, 1703-1710, 2021 | 7 | 2021 |
| Colorectal Cancer treatment characteristics and Concordance with guidelines in Sri Lanka: results from a hospital-based Cancer Registry DT Wijeratne, S Gunasekara, CM Booth, S Berry, M Jalink, LM Carson, ... JCO Global Oncology 8, e2200004, 2022 | 5 | 2022 |
| Breast cancer-related financial toxicity in Sri Lanka: Insights from a lower middle-income country with free universal public healthcare S Ranawaka, S Gunarathna, S Gunasekera, CM Booth, M Jalink, ... The Oncologist 29 (2), e259-e265, 2024 | 4 | 2024 |